Skip to content

Clinical trials

Glioblastoma trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Country / region: Russia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20081
20091
20121
20131
20151
20172
20193
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Unknown status2
No longer available1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Isarna Therapeutics GmbH2
Novartis Pharmaceuticals2
AbbVie1
Apollomics Inc.1
Blokhin's Russian Cancer Research Center1
Center Trials & Treatment1
Hoffmann-La Roche1
Joint Stock Company European Medical Centre1
Medical Research Council1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma15
Glioma6
Astrocytoma5
Brain Neoplasms4
Ganglioglioma2
Ganglioneuroma2
Gliosarcoma2
Neoplasms2
Neurocytoma2
Oligodendroglioma2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.